Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Alberta Ranks Top for Mining Investment, Australia Falls to Bottom

Striking Miners Grind Bolivian Mine to a Halt

Aquarius Platinum Leaps into the Black

Proposal for a Single National Regulatory Body for Oil and Gas in Australia

Fortescue Metals Plans to Increase Iron Ore Production

Tara west Residents Blockade QGC from Surat Basin

Ivanhoe Australia Looks to Raise $269 Million for Expansion and Debt Repayment

Koongarra May Become 'Off Limits' for Uranium Mining

Bradken MD Says Crisis Over, Growth in Earnings

Zijin Mining Group to Shift Focus from Overseas Expansion to Safety and Environment in China

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.